The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics
Clinical trial NCT00986531 · COMPLETED
Trial details
- NCT number
- NCT00986531
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-10-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.